关注
Tobias B. Huber
Tobias B. Huber
Professor of Medicine
在 uke.de 的电子邮件经过验证 - 首页
标题
引用次数
年份
Role of the anaphylatoxin receptor C5aR2 in angiotensin II induced hypertension and hypertensive end organ damage
L Dreher, M Bode, N Ehnert, C Meyer-Schwesinger, T Wiech, J Köhl, ...
American Journal of Hypertension, hpae082, 2024
2024
Targeting T cell plasticity in kidney and gut inflammation by pooled single-cell CRISPR screening
LUB Enk, M Hellmig, K Riecken, C Kilian, P Datlinger, SL Jauch-Speer, ...
Science Immunology 9 (96), eadd6774, 2024
2024
AB1525 DARATUMUMAB FOR REFRACTORY SYSTEMIC RHEUMATIC DISEASES: A SINGLE CENTER EXPERIENCE
MT Holzer, I Kötter, T Xiong, N Ruffer, FC Feindt, S Melderis, ...
Annals of the Rheumatic Diseases 83 (Suppl 1), 2133-2134, 2024
2024
Temporal change of DNA methylation subclasses between matched newly diagnosed and recurrent glioblastoma
R Drexler, R Khatri, U Schüller, A Eckhardt, A Ryba, T Sauvigny, ...
Acta Neuropathologica 147 (1), 21, 2024
2024
Autoantibodies Targeting Nephrin in Podocytopathies
FE Hengel, S Dehde, M Lassé, G Zahner, L Seifert, A Schnarre, O Kretz, ...
New England Journal of Medicine, 2024
2024
Dual-Energy CT muscle fat fraction as a new imaging biomarker of body composition and survival predictor in critically ill patients
J Erley, K Roedl, AK Ozga, G de Heer, N Schubert, J Breckow, ...
European Radiology, 1-11, 2024
2024
Immune profiling-based targeting of pathogenic T cells with ustekinumab in ANCA-associated glomerulonephritis
J Engesser, R Khatri, DP Schaub, Y Zhao, HJ Paust, Z Sultana, N Asada, ...
2024
A prognostic neural epigenetic signature in high-grade glioma
R Drexler, R Khatri, T Sauvigny, M Mohme, CL Maire, A Ryba, Y Zghaibeh, ...
Nature Medicine, 1-14, 2024
12024
Acute kidney injury predicts mortality in very elderly critically-ill patients
EA Schmidt, S De Rosa, J Müller, P Hüsing, R Daniels, P Theile, ...
European Journal of Internal Medicine, 2024
2024
DEFICIENCY OF THE COMPLEMENT RECEPTOR C5AR2 HAS NO EFFECT ON BLOOD PRESSURE AND END ORGAN DAMAGE IN ANGIOTENSIN II INDUCED HYPERTENSION
L Dreher, M Bode, N Ehnert, GR Herrnstadt, C Meyer-schwesinger, J Köhl, ...
Journal of Hypertension 42 (Suppl 1), e44, 2024
2024
WCN24-220 Associations of biomarkers of podocyte injury with histopathologic lesions and foot process effacement in individuals with glomerular disease
IM Schmidt, M Hassanein, A Verme, S Claudel, S Rosan, C Huynh, ...
Kidney International Reports 9 (4), S107, 2024
2024
Ibrutinib-associated focal segmental glomerulosclerosis and the impact of podocin mutations in chronic lymphocytic leukemia
J Czogalla, S Schliffke, S Lu, M Schwerk, H Petereit, T Zhang, S Liu, ...
Kidney International 105 (4), 877-881, 2024
2024
An antigen-specific chimeric autoantibody receptor (CAAR) NK cell strategy for the elimination of anti-PLA2R1 and anti-THSD7A antibody-secreting cells
L Seifert, K Riecken, G Zahner, J Hambach, J Hagenstein, G Dubberke, ...
Kidney International 105 (4), 886-889, 2024
22024
Assessment and Risk Prediction of Chronic Kidney Disease and Kidney Fibrosis Using Non-Invasive Biomarkers
H Rupprecht, L Catanese, K Amann, FE Hengel, TB Huber, A Latosinska, ...
International Journal of Molecular Sciences 25 (7), 3678, 2024
2024
Non-Invasive Biomarkers for Diagnosis, Risk Prediction, and Therapy Guidance of Glomerular Kidney Diseases: A Comprehensive Review
L Catanese, H Rupprecht, TB Huber, MT Lindenmeyer, FE Hengel, ...
International Journal of Molecular Sciences 25 (6), 3519, 2024
2024
Metabolic communication by SGLT2 inhibition
AM Billing, YC Kim, S Gullaksen, B Schrage, J Raabe, A Hutzfeldt, ...
Circulation 149 (11), 860-884, 2024
162024
The 14th International Podocyte conference 2023: From podocyte biology to glomerular medicine
S Koehler, F Hengel, B Dumoulin, L Damashek, LB Holzman, K Susztak, ...
Kidney International, 2024
2024
Urinary peptidomic liquid biopsy for non-invasive differential diagnosis of chronic kidney disease
E Mavrogeorgis, T He, H Mischak, A Latosinska, A Vlahou, JP Schanstra, ...
Nephrology Dialysis Transplantation 39 (3), 453-462, 2024
62024
Daratumumab as rescue therapy in life-threatening granulomatosis with polyangiitis
M Krusche, T Oqueka, D Wichmann, S Kluge, TB Huber, I Kötter, ...
Rheumatology 63 (3), e94-e95, 2024
32024
Cisplatin Nephrotoxicity Is Critically Mediated by the Availability of BECLIN1
T Bork, C Hernando-Erhard, W Liang, Z Tian, K Yamahara, TB Huber
International Journal of Molecular Sciences 25 (5), 2560, 2024
2024
系统目前无法执行此操作,请稍后再试。
文章 1–20